Clinical Trial Update: High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing high versus low dose supplemental external radiation using Palladium-103 for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pd-103 (Palladium-103)

Snippet

Sponsor: VA Puget Sound Health Care System | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED